Rates of decline in regions of the visual field defined by frequency-domain optical coherence tomography in patients with RPGR-mediated X-linked retinitis pigmentosa

Ophthalmology

Volumn 122, Issue 4, 2015, Pages 833-839

  Birch, David G ^a,b   Locke, Kirsten G ^a   Felius, Joost ^a,b   Klein, Martin ^a   Wheaton, Dianna K H ^a,b   Hoffman, Dennis R ^a,b   Hood, Donald C ^c  

^a RETINA FOUNDATION OF THE SOUTHWEST   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; ELLIPSOID ZONE; GENE MUTATION; HUMAN; LONGITUDINAL STUDY; OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; OUTCOME ASSESSMENT; PERIMETRY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA MACULA LUTEA; RETINITIS PIGMENTOSA; VISUAL FIELD; VISUAL SYSTEM PARAMETERS; X LINKED RETINITIS PIGMENTOSA; ADOLESCENT; ADULT; CHILD; FEMALE; FOLLOW UP; GENETIC DISEASES, X-LINKED; GENETICS; MALE; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA; SENSITIVITY AND SPECIFICITY; VISUAL ACUITY; VISUAL DISORDER; YOUNG ADULT;

EYE PROTEIN; RPGR PROTEIN, HUMAN;

ADOLESCENT; ADULT; CHILD; EYE PROTEINS; FEMALE; FOLLOW-UP STUDIES; GENETIC DISEASES, X-LINKED; HUMANS; MALE; MUTATION; PROSPECTIVE STUDIES; RETINA; RETINITIS PIGMENTOSA; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, OPTICAL COHERENCE; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS; YOUNG ADULT;

EID: 84925378389     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2014.11.005     Document Type: Article

References (22)

1. D.R. Hoffman, K.G. Locke, and D.H. Wheaton A randomized, placebo-controlled clinical trial of docosahexaenoic acid (DHA) supplementation for X-linked retinitis pigmentosa Am J Ophthalmol 137 2004 704 718
2. E.L. Berson, B. Rosner, and M.A. Sandberg Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment Arch Ophthalmol 122 2004 1297 1305
3. E.L. Berson, B. Rosner, and M.A. Sandberg Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A Arch Ophthalmol 128 2010 403 411
4. W. Seiple, C.J. Clemens, and V.C. Greenstein Test-retest reliability of the multifocal electroretinogram and Humphrey visual fields in patients with retinitis pigmentosa Doc Ophthalmol 109 2004 255 272
5. D.C. Hood, R. Ramachandran, and K. Holopigian Method for deriving visual field boundaries from OCT scans of patients with retinitis pigmentosa Biomed Optics Exp 2 2011 1106 1114
6. S.G. Jacobson, T.S. Aleman, and A. Sumaroka Disease boundaries in the retina of patients with Usher syndrome caused by MY07A gene mutations Invest Ophthalmol Vis Sci 50 2009 1886 1894
7. D.C. Hood, C.E. Lin, and M.A. Lazow Thickness of receptor and post-receptor retinal layers in patients with retinitis pigmentosa measured with frequency-domain optical coherence tomography Invest Ophthalmol Vis Sci 50 2009 2328 2336
8. N.V. Rangaswamy, H.M. Patel, and K.G. Locke A comparison of visual field sensitivity to photoreceptor thickness in retinitis pigmentosa Invest Ophthalmol Vis Sci 51 2010 4213 4219
9. D.G. Birch, K.G. Locke, and Y. Wen Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa JAMA Ophthalmol 131 2013 1143 1150
10. R. Ramachandran, L. Zhou, and K.G. Locke A comparison of methods for tracking progression in X-linked retinitis pigmentosa using frequency domain OCT Transl Vis Sci Technol 2 2013 1 9
11. D.R. Hoffman, D.K. Hughbanks-Wheaton, and S.N. Pearson Four-year placebo-controlled trial of docosahexaenoic acid in X-linked retinitis pigmentosa (DHAX trial) A randomized clinical trial JAMA Ophthalmol 132 2014 866 873
12. B.J. Lujan, A. Roorda, R.W. Knighton, and J. Carroll Revealing Henle's fiber layer using spectral domain optical coherence tomography Invest Ophthalmol Vis Sci 52 2011 1486 1492
13. R.F. Spaide, and C.A. Curcio Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model Retina 31 2011 1609 1619
14. E.J. Fernandez, B. GHermann, and B. Povazay Ultrahigh resolution optical coherence tomography and pancorrection for cellular imaging of the living human retina Optics Express 16 2008 11083 11094
15. Y. Wen, M. Klein, D.C. Hood, and D.G. Birch Relationships among multifocal electroretinogram amplitude, visual field sensitivity, and SD-OCT receptor layer thicknesses in patients with retinitis pigmentosa Invest Ophthalmol Vis Sci 53 2012 833 840
16. M.A. Sandberg, R.J. Brockhurst, A.R. Gaudio, and E.L. Berson The association between visual acuity and central retinal thickness in retinitis pigmentosa Invest Ophthalmol Vis Sci 46 2005 3349 3354
17. D.C. Hood, M.A. Lazow, and K.G. Locke The transition zone between healthy and diseased retina in patients with retinitis pigmentosa Invest Ophthalmol Vis Sci 52 2011 101 108
18. M.A. Lazow, D.C. Hood, and R. Ramachandran Transition zones between healthy and diseased retina in choroideremia (CHM) and Stargardt disease (STGD) as compared to retinitis pigmentosa (RP) Invest Ophthalmol Vis Sci 52 2011 9581 9590
19. O.P. Kocaoglu, S.J. Lee, and R.S. Jonnal Imaging cone photoreceptors in three dimensions and in time using ultrahigh resolution optical coherence tomography with adaptive optics Biomed Optics Exp 2 2011 748 763
20. D.G. Birch, and J.L. Anderson Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod degeneration. Vision Science and Its Applications; OSA Technical Digest Series 3 1993 334 337
21. M.A. Sandberg, B. Rosner, and C. Weigel-DiFranco Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations Invest Ophthalmol Vis Sci 48 2007 1298 1304
22. R.W. Massof, G. Dagnelie, and T. Benzschawel First order dynamics of visual field loss in retinitis pigmentosa Clin Vision Sci 5 1990 1 26